ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
8.93 USD +0.64 (+7.72%)

At closeNov 4, 2026, 7:59 PM EST

8.89 -0.04 -0.45%

After hours · Nov 4, 7:59 PM ET

8.21 Day range 8.95
1.95 52-week range 12.43
YTD
+351.01%
1 year
+329.33%

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $135.00KProduct → Revenue: $112.98MExpenses → Selling, General & Admin: $147.18MExpenses → Research & Development: $207.88MExpenses → Other Operating Expenses: $13.51MExpenses → Other Expenses: $95.51MGross Profit → Expenses: $112.53MRevenue → Gross Profit: $112.53MRevenue → Cost of Revenue: $753.00KProduct and Service, Other → Revenue: $306.00KNet Loss → Expenses: $351.40MIncome Tax Benefit$135.00KGross Profit$112.53MNet Loss$351.40MCost of Revenue$753.00KExpenses$464.07MSelling, General & Admin$147.18MResearch & Development$207.88MOther Operating Expenses$13.51MOther Expenses$95.51MRevenue$113.29MProduct$112.98MProduct and Service, Other$306.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

IBRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
113.29M14.74M622.00K240.00K934.00K
112.53M14.74M622.00K240.00K934.00K
-256.03M-344.18M-362.25M-351.30M-330.28M
-351.40M-413.56M-583.20M-416.57M-346.79M
-0.38-0.62-1.15-1.04-0.89
IBRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.33M143.43M265.45M104.64M181.10M
501.90M382.93M504.45M362.36M468.91M
1.00B871.06M1.09B812.18M712.82M
842.69M788.57M882.14M723.77M645.66M
-500.47M-489.10M-586.99M-447.33M-242.17M
IBRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-304.94M-391.24M-366.76M-337.51M-274.42M
-149.80M-12.25M-30.47M27.30M-84.89M
400.24M281.63M558.34M233.61M505.44M
-4.25M-6.89M-30.58M-78.16M-13.06M
-54.48M-121.88M160.82M-76.31M146.19M